![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Bladder Cancer |
|
Free Subscription
1 Am Soc Clin Oncol Educ Book |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Bladder Cancer is free of charge.
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and
Emerging Paradigms.
Am Soc Clin Oncol Educ Book. 2026;46:e516902.
PubMed
Abstract available
Reply to Letter to the Editor: 'ALBAN (GETUG-AFU 37): a phase 3, randomized,
open-label, international trial of intravenous atezolizumab and intravesical
Bacillus Calmette-Guerin (BCG) versus BCG alone in BCG-naive high-risk,
non-muscle invasive bladd
Ann Oncol. 2026 Mar 3:S0923-7534(26)00046-3. doi: 10.1016/j.annonc.2026.
PubMed
Identification of SLC3A2 as a Potential Therapeutic Target of Ferroptosis in
Bladder Cancer.
Arch Esp Urol. 2026;79:36-48.
PubMed
Abstract available
Biochim Biophys Acta Rev Cancer
Decoding the metabolic-immune axis for novel therapeutics in bladder cancer.
Biochim Biophys Acta Rev Cancer. 2026 Mar 2:189569.
PubMed
Abstract available
Is there still a role for ureteric frozen section analysis during radical
cystectomy?
BJU Int. 2026;137:659-666.
PubMed
Abstract available
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After
Radical Cystectomy: A Multicenter Study in Japan.
Cancer Sci. 2026;117:739-748.
PubMed
Abstract available
Infiltrated penile papules as a cutaneous manifestation of disseminated BCGitis:
A rare dermatologic presentation.
Int J STD AIDS. 2026;37:444-446.
PubMed
Abstract available
Prognostic Significance of Tertiary Lymphoid Structure-Like Lymphocyte Aggregates
in Routine Histopathological Examination in Bladder Cancer.
Int J Urol. 2026;33:e70392.
PubMed
Abstract available
Preoperative selective arterial embolization followed by transurethral resection
of bladder tumor for large bladder tumors: Early clinical experiences.
Investig Clin Urol. 2026;67:162-169.
PubMed
Abstract available
Budget impact model of nadofaragene firadenovec for the treatment of high-risk
non-muscle-invasive bladder cancer that is unresponsive to Bacillus
Calmette-Guerin immunotherapy.
J Med Econ. 2026;29:672-687.
PubMed
Abstract available
Targeting neuropilin-1 and neutralizing interleukin-6 inhibits cancer stem cell
formation in bladder cancer cells.
J Transl Med. 2026 Mar 4. doi: 10.1186/s12967-026-07943.
PubMed
Dabogratinib (TYRA-300), an FGFR3 Isoform-Selective Inhibitor: Preclinical and
Initial Clinical Evidence of Antitumor Activity.
Mol Cancer Ther. 2026;25:408-415.
PubMed
Abstract available
Turkish urologists' knowledge and attitudes on lifestyle advice for bladder
cancer: a national survey.
Support Care Cancer. 2026;34:260.
PubMed
Abstract available
Thank you for your interest in scientific medicine.